Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial

Hairy cell leukemia (HCL) remains an incurable disease. However, first-line treatment with either intravenous or subcutaneous cladribine generally leads to long-lasting remissions. Although there are excellent long-term data for intravenous application, similar data regarding subcutaneous administra...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Benz, Rudolf, Arn, Kornelius, Andres, Martin, Pabst, Thomas, Baumann, Michael, Novak, Urban, Hitz, Felicitas, Hess, Urs, Zenhaeusern, Reinhard, Chalandon, Yves, Mey, Ulrich, Blum, Sabine, Rauch, Daniel, O'Meara Stern, Alix, Cantoni, Nathan, Bargetzi, Mario, Bianchi-Papina, Elena, Rossi, Davide, Passweg, Jakob, Lohri, Andreas, Berardi, Simona, Li, Qiyu, Feller, Anita, Stussi, Georg
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2020
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7422123/
https://ncbi.nlm.nih.gov/pubmed/32777066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002160
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados